SCHEMBL16520550

SCHEMBL16520550

CC1=CC=C(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.67
▸ PIK3CA P42336 1/20 0.67
▸ PIK3CB P42338 1/20 0.67
▸ PIK3CG P48736 1/20 0.67
▸ MEN1 O00255 13/20 0.44
▸ KMT2A Q03164 13/20 0.44
▸ MAPT P10636 12/20 0.44
▸ HTT P42858 6/20 0.44
▸ KDM4E B2RXH2 6/20 0.44
▸ GAA P10253 3/20 0.44
▸ POLB P06746 3/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ BRCA1 P38398 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ LMNA P02545 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1792641 0.80 PIK3CD (1.00) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL14053013 0.78 PIK3CD (0.80) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL20644802 0.76 PIK3CD (0.73) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL22225700 0.76 PIK3CD (0.76) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL1790968 0.75 PIK3CD (0.77) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL22225674 0.74 PIK3CD (0.74) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL22225686 0.74 PIK3CD (0.70) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL22225697 0.72 PIK3CD (0.61) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL22225682 0.72 PIK3CG (0.69) PIK3CDPIK3CAPIK3CBPIK3CGMEN1
SCHEMBL1791900 0.71 MEN1 (0.72) PIK3CDPIK3CAPIK3CBPIK3CGMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150056191-A1 IGF1 BIOMARKER FOR IGF1R INHIBITOR THERAPY MERCK SHARP & DOHME CORP. 2015-02-26 — — US disclosed
US-20150056191-A1 IGF1 BIOMARKER FOR IGF1R INHIBITOR THERAPY MERCK SHARP & DOHME CORP. 2015-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150056191-A1 IGF1 BIOMARKER FOR IGF1R INHIBITOR THERAPY IGF1R, IGFBP1, IGF2BP2 PIK3CD 1926/4885PIK3CA 607/4885PIK3CB 1304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback